Company News

Increases revenues by more than 1000 per cent over the comparable quarter of 2020 BevCanna Enterprises Inc. an emerging leader in innovative health and wellness beverages and products, today reported its unaudited financial results for the quarter ended September 30, 2021. Third Quarter Company Highlights Delivered revenue growth of over 1,000 per cent to $1.1 million during the quarter ended September 30, 2021, ...

Increases revenues by more than 1000 per cent over the comparable quarter of 2020

BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) ("BevCanna" or the "Company"), an emerging leader in innovative health and wellness beverages and products, today reported its unaudited financial results for the quarter ended September 30, 2021.

Third Quarter Company Highlights (All Amounts Reported in $CAD; Unaudited; prepared in accordance with International Financial Reporting Standards)

  • Delivered revenue growth of over 1,000 per cent to $1.1 million during the quarter ended September 30, 2021, compared to $94,000 comparable quarter of 2020
  • Gross Profit of $356,168 during the quarter ended September 30, 2021, compared to a loss of $40,280 comparable quarter of 2020
  • Cash as of September 30, 2021, of $655,563 compared to $1.0 million as of December 31, 2020
  • Announced a definitive agreement to acquire Embark Health Inc. ("Embark"), a leader in solventless cannabis extraction and enhanced delivery technology, with a focus on the formulation and production of advanced cannabis 2.0 products for the B2B, medical and adult-use markets
  • Obtained product listings and purchase orders from British Columbia Liquor Distribution Branch (BCLDB), Alberta Gaming and Liquor Commission and Ontario Cannabis Store, and successfully shipped product to British Columbia and Ontario. Subsequent to quarter end, the initial shipment of the award-winning Keef Brands line of cannabis-infused beverages to the BCLDB sold out online
  • Announced a definitive agreement with The Tinley Beverage Company Inc. (CSE:TNY, OTCQX:TNYBF) to co-manufacture its award-winning cannabis-infused beverages for the Canadian market
  • BevCanna's Naturo Group announced a supply agreement with B.C. Ministry of Forests to supply B.C. firefighters with custom limited-edition TRACE alkaline waters
  • Announced that its market-leading TRACE line of natural alkaline spring waters will be the official Water Supplier of the Canadian E-Prix/2022 Vancouver E-Prix event, including the highly anticipated Formula E electric car race, part of the ABB FIA Formula E World Championship series

Recent Highlights (Subsequent to Quarter End)

  • On October 5, 2021, BevCanna's Naturo Group announced that it has finalized an agreement with leading North American wholesaler distributor United Natural Foods, Inc. (UNFI). UNFI Canada will now distribute BevCanna's TRACE line of products to retailers across Canada. The UNFI agreement represents a significant milestone for BevCanna. UNFI Canada is a subsidiary of UNFI, the largest publicly traded wholesale distributor in North America
  • On October 7, 2021, BevCanna announced that it has entered into a white-label agreement with Xebra Brands Ltd., a rising player in the global cannabis beverage sector
  • On October 14, 2021, the Company announced that it has entered into an agreement to manufacture and distribute white-label cannabis beverages for Averi Health Products ("Averi"). Averi is a new adult alternative beverage company founded by Terry Donnelly, former CEO of the award-winning Hill Street Beverage Co.
  • On October 21, 2021, BevCanna announced that it has been granted an amendment to its Health Canada-authorized Cannabis Research License, to include sensory evaluations of cannabis beverages in its product development trials. This update to the License will allow BevCanna to conduct on-site human assessments of the taste, smell, feel and visual appeal of its products in development, opening significant opportunities in the formulation and refinement of BevCanna's products and those of its white-label clients

Management Commentary

"As we closed out the third quarter, we delivered impressive revenue growth of more than 1,000 per cent, achieving $1.1 million in sales, compared to $94,000 in the year ago quarter," commented John Campbell, Chief Financial Officer of BevCanna. "Our third quarter results are further evidence of the Company's continued execution and the impact that our brands are having on the market.

"Our unique and diverse portfolio continues to expand, and with the impending close of our acquisition of Embark, will include an even wider range of adult-use and wellness channels and innovative product categories," continued Mr. Campbell. "We look forward to welcoming Embark and its team and remain laser-focused on our go-forward organic growth, while continuing to pursue complementary acquisitions, with the goal of further diversifying our brand offerings in the health and wellness categories."

The unaudited consolidated financial statements and Management Discussion and Analysis for the quarter ended September 30, 2021, are available at .

AGM Results: shareholders approved all matters considered at the Company's Annual General and Special Meeting of Shareholders ("AGM") held November 24, 2021.

Voting Results

Full details of the matters that were voted on at the AGM of Company shareholders held on November 24, 2021, are set out in the Company's Management Information Circular dated October 25, 2021, which is available on SEDAR.

1. Election of Directors

The following persons were elected to serve as directors of the Company, with the outcome of votes being as follows:


% of Votes for

% of Votes Withheld

Marcello Leone



John Campbell



Martino Ciambrelli



Phil Fontaine



William Macdonald



Howard Blank



Douglas Mason



2. Appointment of Auditor

Dale Matheson Carr-Hilton Labonte LLP (DMCL) has been re-appointed as the auditor of the Company for the ensuing year and the Director were authorized to fix the renumeration.

% Of Votes for

% of Votes Withheld



3. Amendment to Articles

The Company's shareholders also approved an amendment to the Company's articles to create a new class of preferred shares issuable in series as more particularly described in the Management Information Circular.

About BevCanna Enterprises Inc.

BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) is a diversified health & wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based, and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing, and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories.

Based in British Columbia, Canada, BevCanna owns a pristine alkaline spring water aquifer and a world–class 40,000–square–foot, HACCP certified manufacturing facility, with a bottling capacity of up to 210M bottles annually. BevCanna's extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with #1 U.S. cannabis beverage company Keef Brands.

Forward-Looking Disclaimer

This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events, or developments that the Company believes, expects, or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding: the prospective synergies between the business of BevCanna and Embark and the business of the Company following the closing of the acquisition of Embark; forecasted revenues of the Company in the fourth quarter of 2021 and for the financial year ended December 31, 2022; future product offerings; the potential benefits of various commercial agreements and partnerships; and other statements regarding the business of the Company. The forward-looking statements reflect management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements.

Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include, among other things: that the CSE may not approve the acquisition of Embark as proposed or at all; that the parties may not be able to satisfy the conditions to closing of the acquisition of Embark; general market conditions; risks associated with the COVID-19 pandemic; and other factors beyond the control of the parties. BevCanna expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law, and the Company does not assume any liability for disclosure relating to any other company mentioned herein.

On behalf of the Board of Directors:
John Campbell, Chief Financial Officer and Chief Strategy Officer
Director, BevCanna Enterprises Inc.

For investor enquiries, please contact:
Shannon Devine, MZ North America

For media enquiries or interviews, please contact:
Wynn Theriault, Thirty Dash Communications Inc.

News Provided by Business Wire via QuoteMedia

Avicanna Announces Closing of Non-Brokered Private Placement of Convertible Debenture Units

Avicanna Announces Closing of Non-Brokered Private Placement of Convertible Debenture Units


Avicanna Inc. (" Avicanna " or the " Company ") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), an innovative, commercial stage, and international biopharmaceutical company focused on the development advancement, and commercialization of evidence-based, cannabinoid-based products, is pleased to announce that it has closed a non-brokered private placement (the " Offering ") of 1,626 convertible debenture units of the Company (the " Units ") at a price of $800 per Unit (representing an original issue discount equal to 20%), for aggregate gross proceeds of approximately $1,550,400. Each Unit consists of an aggregate of $1,000 principal amount of secured subordinated convertible debentures (the " Debentures ") and 545 common share purchase warrants (each, a " Warrant ").

Keep reading... Show less

Curaleaf Announces Revised Date of Fourth Quarter and Fiscal Year End 2021 Earnings Conference Call

Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) ("Curaleaf" or the "Company") a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the fourth quarter and fiscal year ended December 31, 2021 after market close on March 3, 2022 .

Management will host a conference call and audio webcast that evening at 5:00 p.m. ET consisting of prepared remarks followed by a question and answer session related to the Company's operational and financial highlights.

Keep reading... Show less
36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022

36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022

The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th - 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience

The virtual conference begins on Tuesday, February 8th, 2022, with company presentations beginning at 8:30 am Eastern Time. Presentations will be webcast on Tuesday and Wednesday (February 8th and 9th) with 1x1 Meetings being held on Thursday and Friday (February 10th and 11th).

Keep reading... Show less

Trulieve Announces Closing of $75 Million Private Placement of 8% Senior Secured Notes

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that it has closed a second tranche of its previously announced private placement of 8% Senior Secured Notes due 2026 (the "Notes") for aggregate gross proceeds of US$75.0 million (the "Offering"). Together with the first offering of Notes, which closed on October 6, 2021 Trulieve has issued Notes totaling aggregate gross proceeds of US$425.0 million .

The Notes have the same terms as those issued on October 6, 2021 . The press release from the closing of the October 2021 offering can be found here.

Keep reading... Show less

Cresco Labs Announces Launch of Khalifa Kush Products at Cookies Dispensaries Throughout California

Wiz Khalifa's bestselling cannabis brand expanded to California through an exclusive cultivation & product collaboration with the Company's FloraCal Farms and Continuum platform

Cresco Labs (CSE:CL) (OTCQX:CRLBF) ("Cresco Labs" or "the Company"), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced flower and pre-rolls from Khalifa Kush are available for sale at Cookies stores throughout California. Cresco Labs has an exclusive cultivation and product collaboration agreement with multi-platinum-selling, GRAMMY® and Golden Globe® Award-nominated recording artist Wiz Khalifa's cannabis brand. Through the partnership, the Company's FloraCal Farms and Continuum distribution platform will be the sole producer and distributor, respectively, of premium branded products featuring Khalifa Kush's signature "KK" strain in California. An expanded line is expected to arrive at additional retail partners throughout the year.

Keep reading... Show less
closeup of cannabis plant

Australian Cannabis Outlook 2022: Numbers Point to Positive Signs

Click here to read the previous Australian cannabis outlook.

Australia is on a path of building acceptance and understanding of the potential attached to cannabis as a legitimate business. Will 2022 be the year it gains full mainstream status?

The Australian cannabis market saw a significant period of growth in 2021, including both in cannabis spending and the number of patients registered in the country. Additionally, companies in the space continue to explore opportunities abroad with neighbouring markets and friendly cannabis markets.

Here the Investing News Network (INN) provides a snapshot into the expectations for the market in the new year and what some experts are already predicting.

Keep reading... Show less

Latest Press Releases

Related News